Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares RepurchasedShort-Term Debt repayments
Ratios

Pediatrix Medical (MD) Other Gross PP&E Adjustments (2019 - 2025)

Pediatrix Medical (MD) has disclosed Other Gross PP&E Adjustments for 12 consecutive years, with -$31.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 126.03% to -$31.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$31.1 million, a 126.03% decrease, with the full-year FY2025 number at -$31.1 million, down 126.03% from a year prior.
  • Other Gross PP&E Adjustments was -$31.1 million for Q4 2025 at Pediatrix Medical, down from $119.6 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $175.7 million in Q4 2022 to a low of -$61.7 million in Q4 2023.
  • A 5-year average of $74.5 million and a median of $119.6 million in 2024 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: skyrocketed 478.26% in 2021, then tumbled 135.11% in 2023.
  • Pediatrix Medical's Other Gross PP&E Adjustments stood at $169.9 million in 2021, then grew by 3.39% to $175.7 million in 2022, then tumbled by 135.11% to -$61.7 million in 2023, then soared by 293.83% to $119.6 million in 2024, then plummeted by 126.03% to -$31.1 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Other Gross PP&E Adjustments are -$31.1 million (Q4 2025), $119.6 million (Q4 2024), and -$61.7 million (Q4 2023).